Axonics Completes Enrollment of U.S. FDA Pivotal Study for its Sacral Neuromodulation System
June 27, 2018
#Axonics completes enrollment of FDA pivotal trial for sacral nerve neuromod for treatment of urinary and bowel dysfunction. #BioelectronicMedicine
5 views0 comments